Business
Platinum leads immuno-oncology company HaemaLogiX’s $10m round – The Australian Financial Review
Blood cancer immuno-oncology comapny HaemaLogiX is the latest to raise capital, bringing on Platinum Asset Management as its…
KappaMab is designed to enable the immune system to recognise the abnormal cancer cells and kill them.
Platinum Asset Management fund manager Bianca Ogden said the fund had been following the progress of HaemaLogiX and believed now was the right time to…
Continue Reading
-
Noosa News22 hours agoNew self-serve style chip shop, Chip ‘n’ Mix, in Noosa becomes an instant obsession
-
General21 hours agoPoliticians asked how to Trump-proof Australia’s fragile economy on Q+A
-
Noosa News13 hours agoQueensland government to review greenhouse gas emission reduction targets
-
General23 hours agoTeen driver on cocaine racing to Perth nightclub before high-speed crash that killed Nick Campo, court hears